About
Rebiotics Rx is focused on repurposing FDA-approved antibiotics to fight antibiotic-resistant bacteria. The flagship product of Rebiotics Rx is a PEGylated Nanoliposomal-mupirocin formulation. Mupirocin has a unique mode of action, not shared by any other available antibiotic. It is active against pathogens defined as urgent and serious threats to public health, such as Neisseria gonorrhea, methicillin-resistant Staphylococcus aureus, and Streptococcus pneumonia. However, its short half-life in circulation prevents its parenteral use and limits it to topical uses. Reformulation of mupirocin by the nanoliposomes substantially increases the systemic exposure to mupirocin and prolongs its half-life, thereby enabling the parenteral activity of mupirocin and practically resulting in a novel antibiotic with demonstrated efficacy in relevant animal models.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Rebiotics Rx?
- Rebiotics Rx focuses on repurposing FDA-approved antibiotics to combat antibiotic-resistant bacteria.
- What is Rebiotics Rx's flagship product?
- The flagship product of Rebiotics Rx is a PEGylated Nanoliposomal-mupirocin formulation, which aims to enable parenteral activity of mupirocin.
- What is the current operational status of Rebiotics Rx?
- Rebiotics Rx is currently inactive, having ceased operations in May 2021.
- When was Rebiotics Rx founded?
- Rebiotics Rx was founded in February 2018.
- Where is Rebiotics Rx headquartered?
- Rebiotics Rx is headquartered in Jerusalem, Israel.
- Which investor participated in Rebiotics Rx's Seed round?
- Integra Holdings was an investor in Rebiotics Rx's Seed funding round in October 2018.
- What is the employee count for Rebiotics Rx?
- Rebiotics Rx has an employee count of 1-10, with an exact count of 6 employees.
- What is the primary sector of Rebiotics Rx?
- Rebiotics Rx's primary sector is Health Tech & Life Sciences, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the product stage of Rebiotics Rx's offerings?
- Rebiotics Rx's product, Nano-mupirocin, is in the R&D stage.